HUGE News and Press, FSD Pharma Inc. From 07/31/20

Taoping (NASDAQ: TAOP ) -23% . More news on: Taoping Inc., Precipio, Inc., Socket Mobile, Inc., Stocks on the move, , Read more ...

Gainers:  Taoping (NASDAQ: TAOP ) +492% . More news on: Taoping Inc., Edesa Biotech, Inc., DIRTT Environmental Solutions Ltd., Stocks on the move, , Read more ...

FSD Pharma Inc.  (Nasdaq: HUGE) (CSE:  HUGE.CN )announced that it has notified Health Canada of the company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. and suspend all activities by FV Pharma within 30 days of the notification date. FS...

FSD Pharma (NASDAQ: HUGE ) +130% . on decision to surrender health Canada licenses for subsidiary FV Pharma. More news on: FSD Pharma Inc., Kandi Technologies Group, Inc., Edesa Biotech, Inc., Stocks on the move, , Read more ...

FV Pharma to shut down operations within 30 days TORONTO, ON / ACCESSWIRE / July 30, 2020 / FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) (" FSD Pharma " or the " Company ") today announced that it has notified Health Canada of the Company's decision to forfeit the licenses o...

FSD Pharma (NASDAQ: HUGE ) inks an Equity Distribution Agreement with A.G.P./Alliance Global Partners (the “Sales Agent”). More news on: FSD Pharma Inc., Healthcare stocks news, , Read more ...

TORONTO, CANADA / ACCESSWIRE / July 13, 2020 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE) (" FSD Pharma " or the " Company ") today announced that it has entered into an Equity Distribution Agreement dated July 10, 2020 (the " Sales Agreement ") with A.G.P. / Alliance Global Partners (the " S...

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) -  FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing, over time, multiple applications of its lead compound FSD201, has announced favorable topline...

Canadian licensed producer FSD Pharma Inc. (Nasdaq: HUGE) has made a pivot in order to assist in the treatment of the deadly COVID-19 virus. The company announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethan...

Evoke Pharma (NASDAQ: EVOK ) +85%  on FDA approval . More news on: Evoke Pharma, Inc., Theratechnologies Inc., Broadway Financial Corporation, Stocks on the move, , Read more ...